Christine Nowotny
University of Vienna
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christine Nowotny.
Journal of Autoimmunity | 1989
Gere Sunder-Plassmann; Kurt Derfler; Ludwig Wagner; Felix Stockenhuber; Maria Endler; Christine Nowotny; Peter Balcke
Pre-eclampsia is a severe complication in pregnancy, manifested by hypertension, proteinuria and oedema, and in the most severe cases leading to fetal death. Immunological mechanisms are generally assumed to be of major importance in the genesis of the disease. Foidart showed anti-laminin antibodies to be involved in preeclampsia. [ 11. Circulating immune complexes [2] and complement activation [3] as well as alterations in T-cell subsets [4] and suppressor activity [5] have also been observed, but still there remains much uncertainty about the pathophysiological mechanisms involved. IL-2 is an important cytokine in the T-cell pathway [6] as it is released by antigenstimulated T cells and enhances alloantigen reactivity by augmentation of cellular cytytoxic function. The question of whether increased cytokine release can be used as a diagnostic marker for an ongoing alteration of maternofetal immune response prompted us to study the serum activity of IL-2 in pregnant women suffering from pre-eclampsia.
Thrombosis Research | 1996
Martin Ulm; Reinhard Obwegeser; Barbara Ploeckinger; Christine Nowotny; Johann Pidlich; Helmut Sinzinger
Coronary heart disease and myocardial infarction (MI) is rarely seen in women below the age of 40 years and even more rarely during pregnancy. The first case of MI during pregnancy was described by Katz in 1992 (1). Current literature reviewed by Samara et al. 1989 (2) listed only 62 cases of proven MI during pregnancy or in the puerperium, the maternal mortality rate being as high as 24%. In this paper we are going to report on a 26-year old pregnant woman suffering from MI, probably as a result of a haemostatic imbalance caused by a lack of prostacyclin synthesis stimulating plasma factor (PF) and elevated lipoprotein (a) (Lp (a)). The potentially deleterious thromboembolic complications in patients with PF-deficiency, especially in combination with elevated Lp (a), should be carefully considered.
Gynakologisch-geburtshilfliche Rundschau | 1990
Christine Nowotny; Peter Balcke; Kurt Derfler; Margit Endler; A. Feiks; A. Lapin; G. Sunder-Plassman
Gynakologisch-geburtshilfliche Rundschau | 1990
Christine Nowotny; M. Miksche; H. Kölbl; G. Gitsch; E. Hanzal; T. Szepesi
Gynakologisch-geburtshilfliche Rundschau | 1989
Christine Nowotny; Margit Endler; Kurt Derfler; A. Feiks; A. Lapin; Gere Sunder-Plassmann; Peter Balcke
Gynakologisch-geburtshilfliche Rundschau | 1989
Margit Endler; Christine Nowotny; Peter Balcke; Kurt Derfler
Gynakologisch-geburtshilfliche Rundschau | 1989
A. Feiks; R. Rudelstorfer; Josef Deutinger; Kinga Chalubinski; Christine Nowotny; W. Gruber
Gynakologisch-geburtshilfliche Rundschau | 1988
Margit Endler; Christine Nowotny; Peter Balcke; Ch. Hauser; Kurt Derfler
Gynakologisch-geburtshilfliche Rundschau | 1988
Christine Nowotny; O. Balcke; Margit Endler; A. Feiks; Gere Sunder-Plassmann; Kurt Derfler; H. Janisch
Gynakologisch-geburtshilfliche Rundschau | 1988
A. Feiks; Christine Nowotny; W. Gruber